166 related articles for article (PubMed ID: 30262706)
21. [Alveolar microlithiasis: about a new case].
Zaghba N; Hachimi KE; Benjelloun H; Yassine N
Pan Afr Med J; 2017; 28():241. PubMed ID: 29881486
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary alveolar microlithiasis with homozygous c.316G > C (p.G106R) mutation: a case report.
Özbudak IH; Başsorgun CI; Ozbılım G; Lülecı G; Sarper A; Erdoğan A; Taylan F; Altiok E
Turk Patoloji Derg; 2012; 28(3):282-5. PubMed ID: 23011834
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary Alveolar Microlithiasis.
Saito A; McCormack FX
Clin Chest Med; 2016 Sep; 37(3):441-8. PubMed ID: 27514591
[TBL] [Abstract][Full Text] [Related]
24. [Pulmonary alveolar microlithiasis caused by SLC34A2 gene compound heterozygous variations in a child].
Liu DG; Zhuang SX; Zhang CC; Wang LB
Zhonghua Er Ke Za Zhi; 2022 Jul; 60(7):715-716. PubMed ID: 35768363
[TBL] [Abstract][Full Text] [Related]
25. Severe pulmonary hypertension in pulmonary alveolar microlithiasis: A comprehensive literature review.
Cueto-Robledo G; Cantero-Ceballos MD; Gonzalez-Hermosillo LM; Navarro-Vergara DI; Garcia-Cesar M; Torres-Rojas MB; Hernandez-Villa L; Serrato BG; Alfaro-Cruz A
Curr Probl Cardiol; 2024 May; 49(5):102453. PubMed ID: 38342349
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary alveolar microlithiasis: two case reports and review of the literature.
Jönsson ÅL; Simonsen U; Hilberg O; Bendstrup E
Eur Respir Rev; 2012 Sep; 21(125):249-56. PubMed ID: 22941890
[TBL] [Abstract][Full Text] [Related]
27. [Detection of SLC34A2 in patients with pulmonary alveolar microlithiasis and the effect of SLC34A2 on transportation of calcium and phosphate in human alveolar epithelial cells].
Yang Y; Qiao JH; An JH; Zhang Y; Yu T; Jia B; Ma ZS
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):908-11. PubMed ID: 19134407
[TBL] [Abstract][Full Text] [Related]
28. Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations.
Chen YF; Hsieh MS; Wu SG; Chang YL; Shih JY; Liu YN; Tsai MF; Tsai TH; Yu CJ; Yang JC; Yang PC
J Thorac Oncol; 2014 Aug; 9(8):1171-9. PubMed ID: 25157770
[TBL] [Abstract][Full Text] [Related]
29. Identifying and targeting ROS1 gene fusions in non-small cell lung cancer.
Davies KD; Le AT; Theodoro MF; Skokan MC; Aisner DL; Berge EM; Terracciano LM; Cappuzzo F; Incarbone M; Roncalli M; Alloisio M; Santoro A; Camidge DR; Varella-Garcia M; Doebele RC
Clin Cancer Res; 2012 Sep; 18(17):4570-9. PubMed ID: 22919003
[TBL] [Abstract][Full Text] [Related]
30. 3D culture system containing gellan gum restores oncogene dependence in ROS1 rearrangements non-small cell lung cancer.
Gong B; Oh-Hara T; Fujita N; Katayama R
Biochem Biophys Res Commun; 2018 Jun; 501(2):527-533. PubMed ID: 29738763
[TBL] [Abstract][Full Text] [Related]
31. Is SLC34A2 Associated With Concomitant Calcium Metabolism Disorder in Pulmonary Alveolar Microlithiasis (PAM)?
Pascual-González Y; Luburich P; Cuevas E; Vicens-Zygmunt V
Arch Bronconeumol; 2023 Jul; 59(7):469-470. PubMed ID: 37217383
[No Abstract] [Full Text] [Related]
32. Activation of RAS family members confers resistance to ROS1 targeting drugs.
Cargnelutti M; Corso S; Pergolizzi M; Mévellec L; Aisner DL; Dziadziuszko R; Varella-Garcia M; Comoglio PM; Doebele RC; Vialard J; Giordano S
Oncotarget; 2015 Mar; 6(7):5182-94. PubMed ID: 25691052
[TBL] [Abstract][Full Text] [Related]
33. Novel human pathological mutations. Gene symbol: SLC34A2. Disease: pulmonary alveolar microlithiasis.
Ellison J
Hum Genet; 2009 Apr; 125(3):333. PubMed ID: 19309776
[No Abstract] [Full Text] [Related]
34. ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.
Aisner DL; Nguyen TT; Paskulin DD; Le AT; Haney J; Schulte N; Chionh F; Hardingham J; Mariadason J; Tebbutt N; Doebele RC; Weickhardt AJ; Varella-Garcia M
Mol Cancer Res; 2014 Jan; 12(1):111-8. PubMed ID: 24296758
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary Alveolar Microlithiasis: A novel patient and brief review of the literature.
de Oliveira Mekonnen A; Schwerk N; Schütz K; Schramm L; Dreissig A; Grewendorf S; Sukdolak C; Dopfer C; Auber B; von Hardenberg S; Happle C
Klin Padiatr; 2022 Sep; 234(5):317-319. PubMed ID: 35139546
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary alveolar microlithiasis: review of the 1022 cases reported worldwide.
Castellana G; Castellana G; Gentile M; Castellana R; Resta O
Eur Respir Rev; 2015 Dec; 24(138):607-20. PubMed ID: 26621975
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary Alveolar Microlithiasis.
Shaw BM; Shaw SD; McCormack FX
Semin Respir Crit Care Med; 2020 Apr; 41(2):280-287. PubMed ID: 32279298
[TBL] [Abstract][Full Text] [Related]
38. SLC34A2 gene mutation may explain comorbidity of pulmonary alveolar microlithiasis and aortic valve sclerosis.
Jönsson ÅL; Hilberg O; Bendstrup EM; Mogensen S; Simonsen U
Am J Respir Crit Care Med; 2012 Feb; 185(4):464. PubMed ID: 22336687
[No Abstract] [Full Text] [Related]
39. A mass spectrometry assay to simultaneously analyze ROS1 and RET fusion gene expression in non-small-cell lung cancer.
Wijesinghe P; Bepler G; Bollig-Fischer A
J Thorac Oncol; 2015 Feb; 10(2):381-6. PubMed ID: 25384172
[TBL] [Abstract][Full Text] [Related]
40. Molecular and clinicopathological characteristics of ROS1-rearranged non-small-cell lung cancers identified by next-generation sequencing.
Cui M; Han Y; Li P; Zhang J; Ou Q; Tong X; Zhao R; Dong N; Wu X; Li W; Jiang G
Mol Oncol; 2020 Nov; 14(11):2787-2795. PubMed ID: 32871626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
